Product Information
PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1144 per EA under NDC 65862051405. Its NADAC has been published 343 times since Dec 4, 2019.
Strength
45 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862051405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200268On Market Since
2/13/2013
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 343 times since Dec 4, 2019, and over the history we have for it it has declined 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1144 per EA |
|---|---|
| All-time high | $0.1794 (Jan 13, 2021) |
| All-time low | $0.0964 (Nov 20, 2024) |
| 52-week high | $0.1305 |
| 52-week low | $0.1124 |
| Median price | $0.1409 |
| Average price | $0.1413 |
| Largest weekly change | -26.2% (Nov 20, 2024) |
| Weeks tracked | 343 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1144 per EA (NDC 65862051405), effective Jun 24, 2026.
How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 21.9%. It has been tracked across 343 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?
Since Dec 4, 2019, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.0964 (Nov 20, 2024) to a high of $0.1794 (Jan 13, 2021), with a median of $0.1409 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE HCL 45 MG TABLET, but none are currently priced below it.
Who manufactures PIOGLITAZONE HCL 45 MG TABLET?
PIOGLITAZONE HCL 45 MG TABLET (NDC 65862051405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification